{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:47:59Z","timestamp":1791899279714,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-026-01568-x","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:08:58Z","timestamp":1784282938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study of post-translational modifications of p53 in multiple myeloma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2541-7254","authenticated-orcid":false,"given":"Elizabeta A.","family":"Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Crist\u00f3bal-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8876-2592","authenticated-orcid":false,"given":"David","family":"Becerro-Recio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"De Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9410-1205","authenticated-orcid":false,"given":"Myriam","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Isidro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-8586","authenticated-orcid":false,"given":"Irena","family":"Misiewicz-Krzeminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7908-0063","authenticated-orcid":false,"given":"Joaqu\u00edn","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-2221","authenticated-orcid":false,"given":"Albert","family":"Oriol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2534-9239","authenticated-orcid":false,"given":"Laura","family":"Rosi\u00f1ol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3393-9570","authenticated-orcid":false,"given":"Juan Jos\u00e9","family":"Lahuerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9183-4857","authenticated-orcid":false,"given":"Jes\u00fas F.","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-1218","authenticated-orcid":false,"given":"Mar\u00eda Victoria","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-8599","authenticated-orcid":false,"given":"Luis A.","family":"Corchete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-9510","authenticated-orcid":false,"given":"Norma C.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"5","key":"1568_CR1","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/cancers15051558","volume":"15","author":"B Puertas","year":"2023","unstructured":"Puertas B, Gonz\u00e1lez-Calle V, Sobejano-Fuertes E, Escalante F, Queiz\u00e1n JA, B\u00e1rez A, et al. Novel agents as main drivers for continued improvement in survival in multiple myeloma. Cancers (Basel). 2023;15(5):1558.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1568_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","volume":"10","author":"F Malard","year":"2024","unstructured":"Malard F, Neri P, Bahlis NJ, Terpos E, Moukalled N, Hungria VTM, et al. Multiple myeloma. Nat Rev Dis Prim. 2024;10(1):45.","journal-title":"Nat Rev Dis Prim"},{"issue":"24","key":"1568_CR3","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1200\/JCO-24-01893","volume":"43","author":"H Avet-Loiseau","year":"2025","unstructured":"Avet-Loiseau H, Davies FE, Samur MK, Corre J, D\u2019Agostino M, Kaiser MF, et al. International Myeloma Society\/International Myeloma Working Group Consensus recommendations on the definition of high-risk multiple myeloma. J Clin Oncol. 2025;43(24):2739\u201351.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1568_CR4","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.3324\/haematol.2017.168872","volume":"102","author":"S Thanendrarajan","year":"2017","unstructured":"Thanendrarajan S, Tian E, Qu P, Mathur P, Schinke C, van Rhee F, et al. The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma. Haematologica. 2017;102(9):e364\u20137.","journal-title":"Haematologica"},{"issue":"9","key":"1568_CR5","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1182\/blood.2020008346","volume":"137","author":"J Corre","year":"2021","unstructured":"Corre J, Perrot A, Caillot D, Belhadj K, Hulin C, Leleu X, et al. del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma. Blood. 2021;137(9):1192\u20135.","journal-title":"Blood"},{"issue":"1","key":"1568_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41375-018-0196-8","volume":"33","author":"BA Walker","year":"2019","unstructured":"Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies F, et al. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis. Leukemia. 2019;33(1):159\u201370.","journal-title":"Leukemia"},{"issue":"7","key":"1568_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jmcb\/mjz060","volume":"11","author":"Y Liu","year":"2019","unstructured":"Liu Y, Tavana O, Gu W. p53 modifications: exquisite decorations of the powerful guardian. J Mol Cell Biol. 2019;11(7):564\u201377.","journal-title":"J Mol Cell Biol"},{"issue":"10","key":"1568_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nrc1455","volume":"4","author":"AM Bode","year":"2004","unstructured":"Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer. 2004;4(10):793\u2013805.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"1568_CR9","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1080\/15384047.2015.1070978","volume":"16","author":"C Castrogiovanni","year":"2015","unstructured":"Castrogiovanni C, Vandaudenard M, Waterschoot B, De Backer O, Dumont P. Decrease of mitochondrial p53 during late apoptosis is linked to its dephosphorylation on serine 20. Cancer Biol Ther. 2015;16(9):1296\u2013307.","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"1568_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.molmed.2010.09.002","volume":"16","author":"C Dai","year":"2010","unstructured":"Dai C, Gu W. p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med. 2010;16(11):528\u201336.","journal-title":"Trends Mol Med"},{"issue":"6","key":"1568_CR11","doi-asserted-by":"publisher","first-page":"a000950","DOI":"10.1101\/cshperspect.a000950","volume":"1","author":"DW Meek","year":"2009","unstructured":"Meek DW, Anderson CW. Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol. 2009;1(6):a000950.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"12","key":"1568_CR12","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.1093\/nar\/gku501","volume":"42","author":"J Loughery","year":"2014","unstructured":"Loughery J, Cox M, Smith LM, Meek DW. Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters. Nucleic Acids Res. 2014;42(12):7666\u201380.","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"1568_CR13","doi-asserted-by":"publisher","first-page":"9278","DOI":"10.1074\/jbc.275.13.9278","volume":"275","author":"K Sakaguchi","year":"2000","unstructured":"Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW, Appella E. Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J Biol Chem. 2000;275(13):9278\u201383.","journal-title":"J Biol Chem"},{"issue":"54","key":"1568_CR14","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.1038\/sj.onc.1204017","volume":"19","author":"JR Jabbur","year":"2000","unstructured":"Jabbur JR, Huang P, Zhang W. DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo. Oncogene. 2000;19(54):6203\u20138.","journal-title":"Oncogene"},{"issue":"32","key":"1568_CR15","doi-asserted-by":"publisher","first-page":"9837","DOI":"10.1021\/bi992454i","volume":"39","author":"A Gatti","year":"2000","unstructured":"Gatti A, Li HH, Traugh JA, Liu X. Phosphorylation of human p53 on Thr-55. Biochemistry. 2000;39(32):9837\u201342.","journal-title":"Biochemistry"},{"issue":"1","key":"1568_CR16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021456118","volume":"118","author":"X Sun","year":"2021","unstructured":"Sun X, Dyson HJ, Wright PE. A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding. Proc Natl Acad Sci USA. 2021;118(1):e2021456118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"1568_CR17","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1101\/gad.12.18.2831","volume":"12","author":"K Sakaguchi","year":"1998","unstructured":"Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 1998;12(18):2831\u201341.","journal-title":"Genes Dev"},{"key":"1568_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-8-27","volume":"8","author":"AK Freeman","year":"2010","unstructured":"Freeman AK, Monteiro AN. Phosphatases in the cellular response to DNA damage. Cell Commun Signal. 2010;8:27.","journal-title":"Cell Commun Signal"},{"issue":"7","key":"1568_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tcb.2004.05.001","volume":"14","author":"CJ Bakkenist","year":"2004","unstructured":"Bakkenist CJ, Kastan MB. Phosphatases join kinases in DNA-damage response pathways. Trends Cell Biol. 2004;14(7):339\u201341.","journal-title":"Trends Cell Biol"},{"issue":"16","key":"1568_CR20","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1182\/blood.2019000241","volume":"134","author":"L Rosi\u00f1ol","year":"2019","unstructured":"Rosi\u00f1ol L, Oriol A, Rios R, Sureda A, Blanchard MJ, Hern\u00e1ndez MT, et al. Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma. Blood. 2019;134(16):1337\u201345.","journal-title":"Blood"},{"issue":"5","key":"1568_CR21","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3324\/haematol.2017.181628","volume":"103","author":"I Misiewicz-Krzeminska","year":"2018","unstructured":"Misiewicz-Krzeminska I, Corchete LA, Rojas EA, Mart\u00ednez-L\u00f3pez J, Garc\u00eda-Sanz R, Oriol A, et al. A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility. Haematologica. 2018;103(5):880\u20139.","journal-title":"Haematologica"},{"issue":"12","key":"1568_CR22","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3267","volume":"9","author":"I Misiewicz-Krzeminska","year":"2019","unstructured":"Misiewicz-Krzeminska I, Isidro I, Guti\u00e9rrez NC. Capillary nano-immunoassay for quantification of proteins from CD138-purified myeloma cells. Bio Protoc. 2019;9(12):e3267.","journal-title":"Bio Protoc"},{"issue":"3","key":"1568_CR23","doi-asserted-by":"publisher","DOI":"10.4161\/23723548.2014.969653","volume":"1","author":"R Kumari","year":"2014","unstructured":"Kumari R, Kohli S, Das S. p53 regulation upon genotoxic stress: intricacies and complexities. Mol Cell Oncol. 2014;1(3):e969653.","journal-title":"Mol Cell Oncol"},{"issue":"3","key":"1568_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1101\/gad.14.3.289","volume":"14","author":"SY Shieh","year":"2000","unstructured":"Shieh SY, Ahn J, Tamai K, Taya Y, Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 2000;14(3):289\u2013300.","journal-title":"Genes Dev"},{"issue":"4","key":"1568_CR25","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.cellsig.2012.12.014","volume":"25","author":"Z Lu","year":"2013","unstructured":"Lu Z, Wan G, Guo H, Zhang X, Lu X. Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. Cell Signal. 2013;25(4):796\u2013804.","journal-title":"Cell Signal"},{"issue":"2","key":"1568_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/sj.emboj.7601519","volume":"26","author":"HH Li","year":"2007","unstructured":"Li HH, Cai X, Shouse GP, Piluso LG, Liu X. A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55. EMBO J. 2007;26(2):402\u201311.","journal-title":"EMBO J"},{"key":"1568_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fonc.2013.00008","volume":"3","author":"M Shimada","year":"2013","unstructured":"Shimada M, Nakanishi M. Response to DNA damage: why do we need to focus on protein phosphatases? Front Oncol. 2013;3:8.","journal-title":"Front Oncol"},{"issue":"6","key":"1568_CR28","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S1097-2765(04)00123-6","volume":"13","author":"HH Li","year":"2004","unstructured":"Li HH, Li AG, Sheppard HM, Liu X. Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression. Mol Cell. 2004;13(6):867\u201378.","journal-title":"Mol Cell"},{"issue":"5383","key":"1568_CR29","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1126\/science.281.5383.1674","volume":"281","author":"S Banin","year":"1998","unstructured":"Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 1998;281(5383):1674\u20137.","journal-title":"Science"},{"issue":"3","key":"1568_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1101\/gad.14.3.278","volume":"14","author":"NH Chehab","year":"2000","unstructured":"Chehab NH, Malikzay A, Appel M, Halazonetis TD. Chk2\/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 2000;14(3):278\u201388.","journal-title":"Genes Dev"},{"issue":"20","key":"1568_CR31","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/onc.2009.71","volume":"28","author":"DP Teufel","year":"2009","unstructured":"Teufel DP, Bycroft M, Fersht AR. Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2. Oncogene. 2009;28(20):2112\u20138.","journal-title":"Oncogene"},{"issue":"53","key":"1568_CR32","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.1038\/sj.onc.1203015","volume":"18","author":"ND Lakin","year":"1999","unstructured":"Lakin ND, Jackson SP. Regulation of p53 in response to DNA damage. Oncogene. 1999;18(53):7644\u201355.","journal-title":"Oncogene"},{"issue":"15","key":"1568_CR33","doi-asserted-by":"publisher","first-page":"12491","DOI":"10.1074\/jbc.C200093200","volume":"277","author":"S Saito","year":"2002","unstructured":"Saito S, Goodarzi AA, Higashimoto Y, Noda Y, Lees-Miller SP, Appella E, et al. ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J Biol Chem. 2002;277(15):12491\u20134.","journal-title":"J Biol Chem"},{"issue":"39","key":"1568_CR34","doi-asserted-by":"publisher","first-page":"37536","DOI":"10.1074\/jbc.M305135200","volume":"278","author":"S Saito","year":"2003","unstructured":"Saito S, Yamaguchi H, Higashimoto Y, Chao C, Xu Y, Fornace AJ, et al. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem. 2003;278(39):37536\u201344.","journal-title":"J Biol Chem"},{"issue":"3","key":"1568_CR35","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137(3):413\u201331.","journal-title":"Cell"},{"issue":"4","key":"1568_CR36","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cell.2009.04.050","volume":"137","author":"JP Kruse","year":"2009","unstructured":"Kruse JP, Gu W. Modes of p53 regulation. Cell. 2009;137(4):609\u201322.","journal-title":"Cell"},{"issue":"10","key":"1568_CR37","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1046\/j.1432-1327.2001.02225.x","volume":"268","author":"E Appella","year":"2001","unstructured":"Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem. 2001;268(10):2764\u201372.","journal-title":"Eur J Biochem"},{"issue":"8","key":"1568_CR38","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/leu.2011.94","volume":"25","author":"DK Walters","year":"2011","unstructured":"Walters DK, Wu X, Tschumper RC, Arendt BK, Huddleston PM, Henderson KJ, et al. Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX. Leukemia. 2011;25(8):1344\u201353.","journal-title":"Leukemia"},{"issue":"21","key":"1568_CR39","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1182\/blood.2023019963","volume":"143","author":"M Kwok","year":"2024","unstructured":"Kwok M, Agathanggelou A, Stankovic T. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies. Blood. 2024;143(21):2123\u201344.","journal-title":"Blood"},{"issue":"2","key":"1568_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ceb.2007.02.009","volume":"19","author":"J Bartek","year":"2007","unstructured":"Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol. 2007;19(2):238\u201345.","journal-title":"Curr Opin Cell Biol"},{"issue":"10","key":"1568_CR41","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.3390\/ijms23105688","volume":"23","author":"JYH Ali","year":"2022","unstructured":"Ali JYH, Fitieh AM, Ismail IH. The role of DNA repair in genomic instability of multiple myeloma. Int J Mol Sci. 2022;23(10):5688.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1568_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1083\/jcb.200111097","volume":"157","author":"VE Galkin","year":"2002","unstructured":"Galkin VE, Orlova A, VanLoock MS, Rybakova IN, Ervasti JM, Egelman EH. The utrophin actin-binding domain binds F-actin in two different modes: implications for the spectrin superfamily of proteins. J Cell Biol. 2002;157(2):243\u201351.","journal-title":"J Cell Biol"},{"issue":"2\u20133","key":"1568_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.febslet.2004.04.066","volume":"567","author":"M Haneda","year":"2004","unstructured":"Haneda M, Kojima E, Nishikimi A, Hasegawa T, Nakashima I, Isobe Kichi. Protein phosphatase 1, but not protein phosphatase 2A, dephosphorylates DNA-damaging stress-induced phospho-serine 15 of p53. FEBS Lett. 2004;567(2\u20133):171\u20134.","journal-title":"FEBS Lett"},{"issue":"5","key":"1568_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2005.10.003","volume":"20","author":"D Chowdhury","year":"2005","unstructured":"Chowdhury D, Keogh MC, Ishii H, Peterson CL, Buratowski S, Lieberman J. gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell. 2005;20(5):801\u20139.","journal-title":"Mol Cell"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01568-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:03:09Z","timestamp":1791896589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01568-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01568-x","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JML has consulting and advisory roles with Novartis, Celgene, Janssen, and Bristol Myers Squibb, receives speakers\u2019 bureau compensation from Novartis, Celgene, Janssen, and Bristol Myers Squibb, and receives research funding from Novartis, Celgene, Janssen, and Bristol Myers Squibb (institutional). AO has consulting and advisory roles with Amgen and Janssen-Cilag, Amgen, and receives research funding from Janssen (institutional). JSM has consulting and advisory roles with Amgen, Bristol Myers Squibb, Celgene, Janssen, MSD, Novartis, Takeda, and Roche. LR receives honoraria from Janssen, Celgene, Amgen, Takeda, Sanofi, GSK and Karyofarm. MVM receives honoraria and speakers\u2019 bureau compensation from Janssen and Celgene, Onyx, Takeda, Novartis, and Bristol Myers Squibb, unconnected with the submitted work. CDR has received travel grants from Beigene. NCG has received honoraria from Janssen and Amgen, and travel grants from Roche, unconnected with the submitted work. The other authors declare they have no conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All patients gave written informed consent in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"179"}}